CytomX Therapeutics Appoints Sean McCarthy as Chief Business Officer
1/5/2011 8:45:26 AM
(BUSINESS WIRE)--CytomX Therapeutics, a biotechnology company focused on the development of proteolytically-activated antibodies, today announced the appointment of Sean McCarthy, D.Phil., as chief business officer. McCarthy has more than 15 years of experience in the biotech industry, including business development, venture capital and program management.
comments powered by